ClinConnect ClinConnect Logo
Search / Trial NCT07044882

Hydrodynamic Piezoelectric Technique in Internal Sinus Lift

Launched by HAMS HAMED ABDELRAHMAN · Jun 22, 2025

Trial Information

Current as of July 27, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new method called the hydrodynamic piezoelectric technique to help place dental implants in the upper jaw, specifically when there isn’t enough bone under the sinus (a space in the cheek area). This technique gently lifts the sinus membrane with more control and less risk of tearing than traditional methods, which can mean less pain and swelling after the procedure. The study will compare this new approach to the usual method, called the osteotome technique, to see which one works better and is safer for patients.

People who might join the study are adults who need dental implants in the back upper jaw but don’t have enough bone for the implant to fit properly—specifically those with 5 to 7 millimeters of bone height in that area. Participants should have good oral hygiene and no active sinus infections or health problems that could affect healing. If you join, you can expect a minimally invasive procedure that lifts the sinus membrane and places the implant at the same time, potentially resulting in less discomfort afterward. This study could help improve implant treatments for people with similar dental needs in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with edentulous free end or bounded posterior maxilla that require implant supported restoration.
  • Patients indicated to internal sinus lifting, where insufficient residual alveolar bone height from the alveolar crest to the floor of the maxillary sinus is found.
  • Patients with residual alveolar bone height that ranges from 5-7 mm according to the tomographic radiographic examination.
  • A good standard of oral hygiene.
  • Exclusion criteria:
  • Patients with residual alveolar bone height less than 5 mm according to the tomographic radiographic examination.
  • Patients with residual alveolar bone height more than 8 mm according to the tomographic radiographic examination, which is not indicated to sinus lifting.
  • Patient with active sinus infection or sinus pathology.
  • History of Oral or intravenous bisphosphonate therapy or any treatments with other medications that may interfere with bone metabolism within the past 12 months.
  • Heavy smokers.
  • Medically compromised patients that are burdened with systemic conditions that contradicts implant placement and interfere with wound healing.
  • Exclusion Criteria:
  • -

About Hams Hamed Abdelrahman

Hams Hamed Abdelrahman is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous scientific methodologies. With a focus on ethical practices and regulatory compliance, the organization prioritizes patient safety and data integrity in all its clinical trials. Leveraging a diverse team of experienced professionals, Hams Hamed Abdelrahman collaborates with healthcare providers and research institutions to facilitate the development of new therapies and interventions that address unmet medical needs across various therapeutic areas.

Locations

Beirut, , Lebanon

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported